
    
      A total of 48 patients is to be included in phase II and 30 patients in prospective cohort
      during the inclusion period of phase II.

      Phase II study treatment:

      Neoadjuvant chemotherapy: Administration of 4 cycles of chemotherapy (3 months) with platinum
      based chemotherapy (carboplatin or cisplatin, at the choice of the investigator) + etoposide.

      Surgery or chemoradiotherapy depending on the tumor localization (the irradiation modalities
      and associated chemotherapy treatment will be left to the discretion of the referring
      radiotherapists according to current recommendations for each localization).

      Prospective cohort:

        -  Surgery (prior to study entry)

        -  Adjuvant chemotherapy : Administration of 4 cycles of chemotherapy (3 months) with
           platinum based chemotherapy (carboplatin or cisplatin, at the choice of the
           investigator) + etoposide.
    
  